| Literature DB >> 32235819 |
Hai Wang1, Xin Zheng1, Zheng-Hai Bai1, Jun-Hua Lv1, Jiang-Li Sun1, Yu Shi1, Hong-Hong Pei1.
Abstract
BACKGROUND Type 2 diabetes mellitus is a global public health problem. Prediabetes may be reversed by weight loss, diet, and lifestyle changes. However, without intervention, between 30-50% of individuals with prediabetes develop type 2 diabetes. This retrospective population study was conducted to develop a predictive model of prediabetes and incident type 2 diabetes mellitus using data from 2004 to 2015 from the DRYAD Japanese hospital database. MATERIAL AND METHODS A retrospective longitudinal population study was conducted using the DRYAD database from Murakami Memorial Hospital, Gifu, Japan, to construct a predictive model for prediabetes and incident type 2 diabetes mellitus in the population. Univariate analysis and multivariate analysis were performed to identify the variables that were associated with prediabetes. These variables were used to construct (75% samples) and verify (25% samples) the predictive model. RESULTS From 2004 to 2015, a total of 11,113 cases were identified. Multivariate logistic regression analysis included the six variables of age, waist circumference, smoking history, the presence of fatty liver, fasting blood glucose (FBG), and glycated hemoglobin (HbA1c) level. Data were used to construct (75% samples) and verify (25% samples) in a predictive model. The area under the receiver operating characteristic (ROC) curve (AUC) of the predictive model was 0.87 (0.85-0.89) in the training cohort and 0.87 (0.86-0.90) in the validation cohort. CONCLUSIONS A prognostic model based on six variables was predictive for incident type 2 diabetes mellitus and prediabetes in a healthy population in Japan.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32235819 PMCID: PMC7148422 DOI: 10.12659/MSM.920880
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
The demographic and clinical characteristics of the patients included in the study.
| Variables | Training cohort (n=8296) | Validation cohort (n=2817) | P value |
|---|---|---|---|
| Age (years) | 43.52±8.50 | 43.40±8.45 | 0.302 |
| Gender (F/M) | 3762/4534 | 1229/1588 | 0.113 |
| BMI (kg/m2) | 22.13±3.11 | 22.18±3.08 | 0.293 |
| Smoking, n (%) | 1942 (23.41%) | 623 (22.12%) | 0.159 |
| Habit of exercise, n (%) | 1412 (17.02%) | 462 (16.40%) | 0.448 |
| Waist circumference (cm) | 76.37±9.18 | 76.67±9.11 | 0.101 |
| Fatty liver, n (%) | 1463 (17.64%) | 507 (18.00%) | 0.663 |
| Alcohol consumption (gm/week) | 47.66±82.36 | 47.47±81.00 | 0.641 |
| ALT (IU/L) | 20.23±15.76 | 20.58±13.12 | 0.093 |
| AST (IU/L) | 18.61±9.60 | 18.85±7.18 | 0.214 |
| GGT (IU/L) | 20.10±17.70 | 20.74±19.53 | 0.207 |
| Total cholesterol (mmol/L) | 5.10±0.86 | 5.13±0.87 | 0.244 |
| HDL (mmol/L) | 1.43±0.38 | 1.43±0.38 | 0.727 |
| Triglyceride (mmol/L) | 0.92±0.67 | 0.92±0.64 | 0.826 |
| HbA1c (%) | 5.15±0.33 | 5.16±0.33 | 0.398 |
| FBG (mmol/L) | 5.15±0.41 | 5.14±0.41 | 0.607 |
| Systolic blood pressure (mmHg) | 114.32±14.89 | 114.59±15.00 | 0.335 |
| Diastolic blood pressure (mmHg) | 71.69±10.30 | 71.88±10.27 | 0.313 |
| Incident diabetes, n (%) | 275 (3.31%) | 98 (3.48%) | 0.676 |
| Follow-up (years) | 7.75±3.05 | 7.79±3.06 | 0.469 |
BMI – body mass index; FBG – fasting blood glucose; ALT – alanine aminotransferase; AST – aspartate aminotransferase; GGT – gamma glutamyl transpeptidase; HDL – high-density lipoprotein; HbA1c – glycated hemoglobin.
The results of univariate analysis and multivariate Cox regression analysis.
| Factor | Univariate analysis | Multivariate analysis |
|---|---|---|
| Age | 1.06 (1.04–1.07), <0.001 | 1.04 (1.02–1.05), <0.001 |
| Gender | ||
| Female | Reference | Reference |
| Man | 2.51 (1.98–3.20), <0.001 | 0.62 (0.45–0.86), <0.004 |
| BMI | 1.24 (1.21–1.27), <0.001 | 1.05 (0.98–1.12), 0.139 |
| Waist circumference | 1.09 (1.08–1.10), <0.001 | 1.03 (1.00–1.05), 0.037 |
| Smoking | ||
| No | Reference | reference |
| Yes | 2.22 (1.80–2.73), <0.001 | 1.76 (1.40–2.21), <0.001 |
| Fatty liver | ||
| No | Reference | Reference |
| Yes | 7.01 (5.70–8.62), <0.001 | 2.21 (1.71–2.87), <0.001 |
| Alcohol consumption | 1.00 (1.00–1.00), 0.001 | 1.00 (1.00–1.00), 0.430 |
| Fasting blood glucose | ||
| <5.6 mmol/L | Reference | Reference |
| ≥5.6 mmol/L and <6.1 mmol/L | 8.98 (7.29–11.07), <0.001 | 3.64 (2.88–4.59), <0.001 |
| Systolic blood pressure | 1.03 (1.03–1.04), <0.001 | 1.00 (0.98–1.01), 0.630 |
| Diastolic blood pressure | 1.05 (1.04–1.06), <0.001 | 1.01 (0.98–1.03), 0.682 |
| ALT | 1.01 (1.01–1.01), <0.001 | 1.01 (1.00–1.02), 0.272 |
| Triglyceride | 1.79 (1.67–1.91), <0.001 | 1.14 (1.00–1.30), 0.058 |
| HbA1c | ||
| <5.7% | Reference | Reference |
| ≥5.7% and <6.5% | 12.13 (9.80–15.03), <0.001 | 4.62 (3.66–5.84), <0.001 |
| AST | 1.01 (1.01–1.01), <0.001 | 1.00 (0.98–1.01), 0.814 |
| Exercise | ||
| No | Reference | Reference |
| Yes | 0.76 (0.57–1.02), 0.069 | 0.99 (0.74–1.34), 0.963 |
| GGT | 1.01 (1.01–1.01), <0.001 | 1.00 (1.00–1.01), 0.167 |
| HDL | 0.15 (0.11–0.21), <0.001 | 0.68 (0.46–1.02), 0.060 |
BMI – body mass index; FBG – fasting blood glucose; ALT – alanine aminotransferase; AST – aspartate aminotransferase; GGT – gamma glutamyl transpeptidase; HDL – high-density lipoprotein; HbA1c – glycated hemoglobin.
Construction of the predictive models.
| Variables | Estimate | Standard error | Odds ratio (OR) (95% CI) | P-value |
|---|---|---|---|---|
| Age | 0.0293 | 0.0079 | 1.03 (1.01–1.05) | <0.001 |
| Gender | −0.2479 | 0.1781 | 0.78 (0.55–1.11) | 0.164 |
| Smoking | 0.7463 | 0.1482 | 2.11 (1.58–2.82) | <0.001 |
| Fatty liver | 1.1448 | 0.1587 | 3.14 (2.30–4.29) | <0.001 |
| Waist circumference | 0.0502 | 0.0083 | 1.05 (1.03–1.07) | <0.001 |
| Fasting blood glucose | 1.4747 | 0.1423 | 4.37 (3.31–5.78) | <0.001 |
| HbA1c | 1.4859 | 0.1546 | 4.42 (3.26–5.98) | <0.001 |
| Age | 0.0297 | 0.0079 | 1.03 (1.01–1.05) | <0.001 |
| Smoking | 0.6796 | 0.1392 | 1.97 (1.50–2.59) | <0.001 |
| Fatty liver | 1.1243 | 0.1575 | 3.08 (2.26–4.19) | <0.001 |
| Waist circumference | 0.048 | 0.0082 | 1.049 (1.03–1.07) | <0.001 |
| Fasting blood glucose | 1.4368 | 0.1391 | 4.21 (3.20–5.53) | <0.001 |
| HbA1c | 1.5198 | 0.1526 | 4.57 (3.39–6.16) | <0.001 |
Figure 1The area under the receiver operating characteristic (ROC) curve (AUC) of the predictive model in the training cohort. The hazard ratio (HR) of the area under the receiver operating characteristic (ROC) curve (AUC) of the predictive model in the training cohort was 0.87 (95% CI, 0.85–0.89). The specificity and sensitivity of the predictive model were 0.79 and 0.82, respectively.
Figure 2The area under the receiver operating characteristic (ROC) curve (AUC) of the predictive model in the validation cohort. The hazard ratio (HR) of the area under the receiver operating characteristic (ROC) curve (AUC) of the validation cohort was 0.87 (95% CI, 0.86–0.90). The specificity and sensitivity of the predictive model were 0.73 and 0.87, respectively.